You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally advanced basal cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Basal Cell Carcinoma Trial in Philadelphia (biological, procedure, other)

Not yet recruiting
  • Locally Advanced Basal Cell Carcinoma
  • Cemiplimab
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jun 28, 2023

Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

Not yet recruiting
  • Basal Cell Carcinoma
  • Radiotherapy; Complications
  • Radiotherapy
  • +2 more
  • (no location specified)
Sep 30, 2022

Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma Trial in Bordeaux (Treatment with vismodegib)

Completed
  • Metastatic Basal Cell Carcinoma
  • Locally Advanced Basal Cell Carcinoma
  • Treatment with vismodegib
  • Bordeaux, France
    Chu de Bordeaux
Aug 17, 2022

Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)

Recruiting
  • Locally Advanced Basal Cell Carcinoma
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Aug 3, 2022

Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,

Recruiting
  • Basal Cell Carcinoma
  • +10 more
  • Nijmegen, Gelderland, Netherlands
  • +7 more
Jul 14, 2022

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real

Completed
  • Basal Cell Carcinoma
    • Essen, Germany
      Klinik und Poliklinik für Dermatologie, Venerologie und Allergol
    Jun 2, 2021

    Basal Cell Carcinoma Trial in Baltimore (Nivolumab, Ipilimumab, Relatlimab)

    Recruiting
    • Basal Cell Carcinoma
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Mar 10, 2022

    Locally Advanced Basal Cell Carcinoma, Skin Cancer, Cutaneous Malignancy Trial in San Francisco, New York (Vismodegib, Radiation

    Completed
    Has Results
    • Locally Advanced Basal Cell Carcinoma
    • +2 more
    • San Francisco, California
    • +1 more
    Apr 7, 2021

    Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Zurich (Talimogene Laherparepvec (T-VEC))

    Completed
    • Non-melanoma Skin Cancer
    • +4 more
    • Talimogene Laherparepvec (T-VEC)
    • Zurich, Switzerland
      Department of Dermatology, University Hospital Zurich
    Mar 17, 2022

    Advanced Basal Cell Carcinoma Trial in Tampa (Vismodegib 150 MG Oral Capsule)

    Recruiting
    • Advanced Basal Cell Carcinoma
    • Vismodegib 150 MG Oral Capsule
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 14, 2022

    The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

    Recruiting
    • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
    • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
    • Hanzhou, Zhejiang, China
      Lulu Liu
    Jul 14, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

    Not yet recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Mar 20, 2023

    Carcinoma, Basal Cell Trial in United States (CX-4945)

    Recruiting
    • Carcinoma, Basal Cell
    • Aurora, Colorado
    • +3 more
    Mar 11, 2022

    Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

    Not yet recruiting
    • Esophageal Carcinoma
    • Immune Checkpoint Inhibitors
    • (no location specified)
    Jul 6, 2023

    Nevoid Basal Cell Carcinomas in Gorlin Syndrome

    Enrolling by invitation
    • Basal Cell Carcinoma
    • Gorlin Syndrome
    • Active surveillance
    • Oslo, Norway
      Oslo University Hospital
    Jun 8, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy

    Not yet recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • Tianjin, China
    • +1 more
    May 16, 2023

    Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

    Not yet recruiting
    • Esophageal Cancer
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Cell Carcinoma Trial in Nice (Tirbanibulin)

    Not yet recruiting
    • Cell Carcinoma
    • Nice, Alpes-maritimes, France
      CHU de Nice - Hôpital de l'Archet
    Oct 27, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)

    Recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Sep 6, 2022

    Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Cadonilimab combined Anlotinib
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Aug 6, 2023

    Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Oct 25, 2023

    Esophageal Squamous Cell Carcinoma Trial in Anyang, Zhengzhou (AK104, nab-paclitaxel, carboplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • AK104, nab-paclitaxel, carboplatin
    • Anyang, Henan, China
    • +1 more
    Jun 1, 2023

    BCC Excision Revisited

    Completed
    • Basal Cell Carcinoma
    • +2 more
    • Surgery
    • Vienna, Austria
      Medical University of Vienna
    May 14, 2023

    Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Nov 30, 2023